Revvity (RVTY) vs Waters (WAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Revvity (RVTY) has outperformed Waters (WAT) over the past year, gaining 65.8% versus a gain of 37.0%. Over five years, WAT leads with a +26.5% price change compared with -10.4% for RVTY. Waters is the larger company by market cap ($42.13 billion vs $16.98 billion), about 2.5 times the size.
On valuation, Revvity trades at a lower forward P/E (25.8x vs 25.9x for Waters). Revvity pays a dividend yielding 0.18%, while Waters does not currently pay one. Waters converts more of its revenue into profit, with a net margin of 20.3% versus 8.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RVTY | WAT |
|---|---|---|
| Share price | $152.16 | $429.13 |
| Market cap | $16.98B | $42.13B |
| 1-day change | -0.94% | -1.57% |
| YTD return | +57.27% | +14.79% |
| 1-year return | +65.81% | +36.95% |
| 5-year return | -10.40% | +26.48% |
| P/E ratio (TTM) | 72.80 | 108.64 |
| Forward P/E | 25.82 | 25.95 |
| EPS (TTM) | $2.09 | $3.95 |
| Dividend yield | 0.18% | 0.00% |
| Annual dividend | $0.28 | $0.00 |
| Revenue (latest FY) | $2.86B | $3.17B |
| Revenue growth (YoY) | +3.67% | +6.99% |
| Net income (latest FY) | $241.20M | $642.63M |
| Gross margin | — | 59.28% |
| Operating margin | 12.49% | 25.36% |
| Net margin | 8.45% | 20.30% |
| 52-week high | $166.25 | $454.54 |
| 52-week low | $81.22 | $282.77 |
| Distance from 52-week high | -8.48% | -5.59% |
| Analyst consensus | buy | buy |
| Avg. price target upside | -10.71% | +6.42% |
| Average volume | 1.79M | 777.61K |
| Shares outstanding | 111.59M | 98.19M |
| Employees | 11,000 | 16,000 |
| Sector | Industrials | Healthcare |
| Industry | Biotechnology: Laboratory Analytical Instruments | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Waters is about 2.5 times larger than Revvity by market value ($42.13B vs $16.98B).
- RVTY has outperformed WAT by 28.9 percentage points over the past year.
- Waters trades at a higher earnings multiple (108.6x vs 72.8x trailing P/E).
- Waters is more profitable, keeping 20.3 cents of every revenue dollar as net income versus 8.4 cents for Revvity.
- The two companies sit in different sectors: Revvity in Industrials and Waters in Healthcare.
About Revvity
RVTY stock →Revvity, Inc. provides health sciences solutions, technologies, and services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees
About Waters
WAT stock →Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.
Healthcare · Diagnostics & Research · 16,000 employees
RVTY vs WAT FAQ
Which is bigger, Revvity or Waters?
Waters (WAT) is larger, with a market capitalization of $42.13B compared with $16.98B for Revvity (RVTY).
Which stock has performed better over the past year, RVTY or WAT?
RVTY returned +65.81% over the past 12 months, compared with +36.95% for WAT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, RVTY or WAT?
RVTY has the lower trailing P/E at 72.8, versus 108.6 for WAT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Revvity or Waters?
Revvity pays a dividend yielding 0.18%, while Waters does not currently pay a regular dividend.
Are Revvity and Waters in the same industry?
No. Revvity is in the Industrials sector, while Waters is in Healthcare.